Internal Medicine By Doha Rawag
3.6K subscribers
1.04K photos
63 videos
62 files
172 links
MBBCh ,Tripoli University๐Ÿ‘ฉโ€๐ŸŽ“
GP at TUH๐Ÿ‘ฉโ€โš•๏ธ
Studies arab and Libyan board of internal medicine specialists ๐Ÿฉบ
Medical educator at https://t.me/New_Minds_Edu๐Ÿ’ป
ุงู„ู‚ู†ุงุฉ ุฎุงุตุฉ ุจูƒู„ ุดูŠ ูŠุชุนู„ู‚ ุจู…ุงุฏุฉ ุงู„ุจุงุทู†ุฉ .๐Ÿ’Š๐Ÿ’‰
Download Telegram
Forwarded from Internal Medicine By Doha Rawag (Doha Ali Rawaq)
โ‡๏ธHypercalcemia and respiratory diseases

Sarcoidosis โžก๏ธpresence of 1ฮฑ-hydroxylase enzyme in macrophages and giant cells that form part of the granuloma.

Squamous cell carcinoma of lung โžก๏ธ
parathyroid hormone-related peptide (PTHrP), a protein that has similar action to parathyroid hormone (PTH) .

ุฑูƒุฒูˆุง ุนู„ูŠู‡ู… ู…ู‡ู…ุงุช ููŠ ุงู„ MCQ๐Ÿ“
โค11๐Ÿ’ฏ1
Forwarded from Internal Medicine By Doha Rawag (Doha Ali Rawaq)
ู…ู‡ู…ุงุงุงุงุงุงุช ุฌุฏุงู‹๐Ÿ“
โค9
Forwarded from Internal Medicine By Doha Rawag (Doha Ali Rawaq)
โœณ๏ธMost common type of lung cancer worldwide is
โžก๏ธ lung adenocarcinoma ๐Ÿ“
โค11๐Ÿ‘2
Forwarded from Internal Medicine By Doha Rawag (Doha Ali Rawaq)
ู…ู‡ู…ุฉ ูˆ ู„ุงุฒู… ูŠุฌูŠ ู…ู†ู‡ุง ุณุคุงู„ ุณูˆุงุก Case ุงูˆ MCQ๐Ÿ“

#light's_criteria
โค6
#Indications_of_Steroids_in_TB:๐Ÿ“

๐Ÿ“Pericarditis +/- Myocarditis
๐Ÿ“Meningitis
๐Ÿ“Adrenalitis
๐Ÿ“Uveitis
๐Ÿ“Paradoxical response
๐Ÿ“Endobronchial LN compression/impending rupture
โค4๐Ÿ‘1
#Manegment of Pneumothorax ๐Ÿ“
โค7
โœ…๏ธStages_of_nail_clubbing๐Ÿ“

1_ Stage 1โžก๏ธ+ve flactuation test
2_ Stage 2โžก๏ธloss of normal angel b/w nail and nail fold
3_ Stage 3โžก๏ธloss of window ( Sham Roths sing )
4_ Stage 4 โžก๏ธDrum stick appearance
5_ Stage 5โžก๏ธ Hyperthrophic pulmonary osteoathropathy
โค3
๐ŸŸจYellow Nail Syndrome

๐Ÿ“Yellow naiks
๐Ÿ“Congenital lymphydema
๐Ÿ“Bronchiactasis / Pleural effusions
๐Ÿ“Chronic sinusitis
๐Ÿ”ฅ6โค2
๐ŸŸจDD of yellow nail

1_Onychomycosis
2_ Chronic paronychia
3_ Pseudonymous infection
4_ Yellow nail syndrome
5_Drugs ( Topical 5`flurouracil , tetracycline)๐Ÿ’Š
๐Ÿ”ฅ6โค2
ุงู„ุจูˆุณุช ู‡ุฐุง ุญูŠู‚ุนุฏ ู…ุญููˆุฑ ููŠ ุฐุงูƒุฑุชูŠ ู…ู‡ู…ุง ุญูŠูŠุช๐Ÿค

ู…ุนุฒ ู‡ูˆ ุจูŠุดู†ุช ู„ูŠูˆูƒูŠู…ูŠุง (ุงู„ุญู…ุฏ ู„ู„ู‡ ุญุงู„ูŠุงู‹ ููŠ ู…ุฑุญู„ุฉ ุงู„ุชุนุงููŠ ูˆ ุฏุนูˆุงุชูƒู… ู„ูŠู‡ ุจูƒู…ุงู„ ุงู„ุตุญุฉ ูˆ ุงู„ุนุงููŠุฉ)
ูˆ ุฃูŠุถุง ุทุงู„ุจ ุณู†ุฉ ุฎุงู…ุณุฉ ู…ู† ุฌุงู…ุนุฉ ุชุฑู‡ูˆู†ุฉ

ุชุนุฑูุช ุนู„ูŠู‡ ูˆู‚ุช ูƒู†ุช rotation ุจู‚ุณู… ุฃู…ุฑุงุถ ุงู„ุฏู… ูˆ ุงู„ุฃูˆุฑุงู… ุจุงุทู†ุฉ ูˆ ู‡ูˆ ุจุงู„ุตุฏูุฉ ูŠุนุฑูู†ูŠ ู…ู† ู‚ู†ุงุชูŠ

ุงู„ู†ุฌุงุญ = ุนุฒูŠู…ุฉ ูˆ ุฅุตุฑุงุฑ ู…ู‡ู…ุง ูƒุงู†ุช ุงู„ุธุฑูˆู ุงู„ู„ูŠ ุงู†ุช ุชู…ุฑ ุจูŠู‡ุง
ู‚ุตุฉ ู†ุฌุงุญ ู†ุจูŠู‡ุง ุชูƒูˆู† ู…ุตุฏุฑ ุชูุงุคู„ ู„ู„ุฌู…ูŠุน๐Ÿ’ช

ุงู„ู„ู‡ู… ุฃู†ูุน ุจู†ุง ุฃูŠู†ู…ุง ูƒู†ุง๐Ÿค
โค88
๐Ÿ“Restrictive/obstructive lung disaeses

๐ŸŸชRestrictive_lung_disease
๐Ÿ‘‰FEV1 - reduced
๐Ÿ‘‰FVC - significantly reduced
๐Ÿ‘‰FEV1% (FEV1/FVC) - normal or increased

โ—พ๏ธMain causes
*Pulmonary fibrosis
*Asbestosis
*Extrinsic hypersensitivity pneumonitis
*Sarcoidosis
*Acute respiratory distress syndrome
*Infant respiratory distress syndrome
*Kyphoscoliosis
*Neuromuscular disorders

๐ŸŸชObstructive_lung_disease
๐Ÿ‘‰FEV1 - significantly reduced
๐Ÿ‘‰FVC - reduced or normal
๐Ÿ‘‰FEV1% (FEV1/FVC) - reduced

โ—พ๏ธMain causes
*Asthma
*COPD
*Bronchiectasis
*Bronchiolitis obliterans
โค7
#COPD_long_term_oxygen_therapy

โœดPatients who receive LTOT should breathe supplementary oxygen for at least 15 hours
a day.

#Assess patients if any of the following:
๐Ÿ’ฅvery severe airflow obstruction (FEV1 < 30% predicted).
๐Ÿ’ฅAssessment should be 'considered' for patients with severe airflow obstruction (FEV1 30-49% predicted)
๐Ÿ’ฅcyanosis
๐Ÿ’ฅpolycythaemia
๐Ÿ’ฅperipheral oedema
๐Ÿ’ฅraised jugular venous pressure
๐Ÿ’ฅoxygen saturations less than or equal to 92% on room air

#Assessment is done by measuring arterial blood gases on 2 occasions at least 3 weeks apart in patients with stable COPD on optimal management.

๐Ÿ“Offer LTOT to patients with

1_ pO2 of < 7.3 kPa (<55 %)
2_to those with a pO2 of 7.3 - 8 kPa and one of the following:
โœ”secondary polycythaemia
โœ”nocturnal hypoxaemia
โœ”peripheral oedema , raised JVP
โœ”pulmonary hypertension
โค6
๐ŸŸจComplcations of COPD

โ—พ๏ธ2ry Polycythemia
โ—พ๏ธCor-Pulmonale
โ—พ๏ธRecurrent infections
(Bronchiectasis)
โ—พ๏ธRupture bullae
โ—พ๏ธPneumothorax
โ—พ๏ธType II Respiratory failure
โค9
๐Ÿ“Causes of pulmonary edema
๐ŸŸฅCardiogenic
Acute HF

๐ŸŸฅNoncardiogenic
๐Ÿ”ต Drowning
๐Ÿ”ต Acute glomerulonephritis
๐Ÿ”ต Fluid overload
๐Ÿ”ต Aspiration
๐Ÿ”ต Inhalation injury
๐Ÿ”ต Opioid overdose
๐Ÿ”ต Salicylate toxicity
๐Ÿ”ต Neurogenic pulmonary edema
๐Ÿ”ต Allergic reaction
๐Ÿ”ต Adult respiratory distress syndrome
๐Ÿ‘4โค2